ContraFect (CFRX) received a Notice of Allowance for its US patent application 16/674,149 - Patent Grants

October 13, 2021 3:36 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

ContraFect (NASDAQ: CFRX) received a Notice of Allowance for its US patent application 16/674,149 titled "ANTIBODIES USEFUL IN PASSIVE INFLUENZA IMMUNIZATION, AND COMPOSITIONS, COMBINATIONS AND METHODS FOR USE THEREOF - Patent Grants



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, FDA, Trader Talk